• #48 - Michael Oleksiw, CEO at Pleio

  • Apr 15 2025
  • Duración: 14 m
  • Podcast

#48 - Michael Oleksiw, CEO at Pleio

  • Resumen

  • Join us on the latest episode! Our Guest: Michael Oleksiw, CEO at Pleio.


    What you'll get out of this episode:

    • Human + AI Synergy: Pleio combines emotionally aware AI with peer-to-patient support to boost medication adherence.
    • Overcoming Emotional Barriers: Emotions like fear, loneliness, and stigma are major challenges after diagnosis.
    • Real-World Impact: Pleio's approach improved adherence rates by up to 28% in GLP-1 medication trials.
    • Ethical AI in Healthcare: Patient data is de-identified and overseen by a medical board to ensure ethical use.
    • Laser Focus on Loneliness: Pleio’s next frontier is tackling loneliness as a primary emotional barrier in healthcare.

    To Learn More About Our Guest And Their Company:
    Guest LinkedIn https://www.linkedin.com/in/michaeloleksiw/
    Company LinkedIn https://www.linkedin.com/company/pleio-inc/
    Website http://www.pleio.com

    Our sponsor for this episode are:
    Sage Growth Partners https://sage-growth.com/

    BioBreakthroughs is part of the Slice of Healthcare podcast network:
    LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

    Más Menos
adbl_web_global_use_to_activate_webcro805_stickypopup

Lo que los oyentes dicen sobre #48 - Michael Oleksiw, CEO at Pleio

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.